Home/Filings/4/0001209191-18-052374
4//SEC Filing

Paul David C 4

Accession 0001209191-18-052374

CIK 0001237831other

Filed

Sep 25, 8:00 PM ET

Accepted

Sep 26, 8:15 PM ET

Size

31.8 KB

Accession

0001209191-18-052374

Insider Transaction Report

Form 4
Period: 2018-09-24
Paul David C
DirectorExecutive Chairman10% Owner
Transactions
  • Conversion

    Class A Common Stock

    2018-09-24+298,647298,647 total(indirect: By Trust)
  • Conversion

    Class A Common Stock

    2018-09-24+298,647298,647 total(indirect: By Trust)
  • Sale

    Class A Common Stock

    2018-09-25$54.70/sh748,845$40,959,1260 total
  • Conversion

    Class B Common Stock

    2018-09-24298,6470 total(indirect: By Trust)
    Class A Common Stock (298,647 underlying)
  • Conversion

    Class B Common Stock

    2018-09-25748,84520,867,524 total
    Class A Common Stock (748,845 underlying)
  • Sale

    Class A Common Stock

    2018-09-24$54.01/sh101,320$5,472,5570 total
  • Conversion

    Class A Common Stock

    2018-09-25+748,845748,845 total
  • Sale

    Class A Common Stock

    2018-09-24$54.01/sh298,647$16,130,7010 total(indirect: By Trust)
  • Sale

    Class A Common Stock

    2018-09-24$54.01/sh298,647$16,130,7010 total(indirect: By Trust)
  • Conversion

    Class B Common Stock

    2018-09-24101,32021,616,369 total
    Class A Common Stock (101,320 underlying)
  • Sale

    Class A Common Stock

    2018-09-24$54.01/sh605,871$32,724,6680 total
  • Conversion

    Class A Common Stock

    2018-09-24+101,320101,320 total
  • Conversion

    Class B Common Stock

    2018-09-24298,6470 total(indirect: By Trust)
    Class A Common Stock (298,647 underlying)
Holdings
  • Class B Common Stock

    (indirect: By Trust)
    Class A Common Stock (1,562,573 underlying)
    1,562,573
Footnotes (8)
  • [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.00 to $54.26, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
  • [F3]The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date.
  • [F4]These shares are held in a trust for the benefit of a child of the reporting person. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  • [F5]These shares are held in a trust for the benefit of a child of the reporting person. The reporting person is trustee of the trust.
  • [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.00 to $55.00, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (6) to this Form 4.
  • [F7]From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock.
  • [F8]These shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse is trustee of the trust.

Issuer

GLOBUS MEDICAL INC

CIK 0001237831

Entity typeother

Related Parties

1
  • filerCIK 0001555391

Filing Metadata

Form type
4
Filed
Sep 25, 8:00 PM ET
Accepted
Sep 26, 8:15 PM ET
Size
31.8 KB